Aster glehni fractions with excellent anti-inflammatory activity and active compounds isolated therefrom

Anti-inflammatory composition containing active compounds derived from Aster glehni

This technology relates to an anti-inflammatory composition containing caffeoyldihydrosyringin and glehnoside compounds isolated from Aster glehni fractions as active ingredients.

While natural products are gaining attention as materials for treating inflammatory diseases, there have been difficulties in identifying and isolating compounds with excellent anti-inflammatory activity for use in compositions.

By using active compounds isolated from Aster glehni as active ingredients to inhibit inflammation, this technology can be applied to pharmaceuticals, health foods, and cosmetics to prevent and improve various inflammatory diseases.

‍

‍

Key Features:

• Pharmaceutical composition for the treatment and prevention of inflammatory diseases containing one or more compounds selected from caffeoyldihydrosyringin and glehnoside
• Health food composition for improving inflammatory diseases containing the corresponding active compounds, their salts, hydrates, or solvates
• Cosmetic composition for improving inflammatory diseases containing the corresponding active compounds, their salts, hydrates, or solvates
• Steps of fractionating Aster glehni extract with water and ethyl acetate, followed by column chromatography to obtain each active compound

‍

This patent is owned by IPBank. Upon purchase, you may receive support through commercialization programs, recommendations for technology transfer and commercialization funding guarantees, and additional points during the evaluation for priority procurement of excellent inventions.

‍